Frazier Life Sciences Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-870,636
Closed -$47.9M 47
2022
Q2
$47.9M Sell
870,636
-1,471,562
-63% -$77.2M 4.52% 8
2022
Q1
$75.1M Buy
+2,342,198
New +$67.2M 6.4% 4

Other funds holding SRRA